Aim: This article aimed to review the effectiveness of pharmacological interventions in improving glycemic control, insulin sensitivity, pancreatic Beta cell function, and other cardiometabolic outcomes in children and adolescents with prediabetes.Method: This review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.Results: Overall, the interventions demonstrated improvements in glycemic control, insulin sensitivity, Beta cell function, and selected cardiometabolic risk markers.Conclusion: Pharmacological interventions may improve glycemic control, insulin sensitivity, Beta cell function, and selected cardiometabolic outcomes in children and adolescents with prediabetes.Keywords: adolescents; children; glycemic control; pharmacological interventions; prediabetes; systematic review.
Copyrights © 2026